Doctor Reveals The BEST GLP-1 For 2026 (Retatrutide vs Tirzepatide)
Dr. Jones, DC — Doctor Reveals The BEST GLP-1 For 2026 (Retatrutide vs Tirzepatide)
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=K7v6DNHB3y8
What this video covers
Reddit true tide the triple receptor activator 29% weight loss in trials. So is it really the best GLP1 for 2026 and beyond? Should you switch from tzepide or saglutide immediately? That’s the third receptor, the glucagon receptor.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Jones DC and I lead the coaching department at our nationwide GLP1 clinic where I work alongside prescribing physicians helping patients optimize these medications every single day.
- Even though the large clinical trials haven’t demonstrated the exact increased risk, I think if you have abnormal heart rhythms, the mechanisms make sense to be concerned.
- It hasn’t been FDA approved yet for a reason.
- We added peptides, cell signaling proteins to address her inflammation, adjusted her approach, and weight loss resumed.
- Pre-clinical studies show that it can stimulate lipolysis in lab models.
- It’s completed phase three trials but it’s not FDA approved yet.
Read next
- GLP-1 class — more videos
- Tirzepatide — more videos
- Retatrutide — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.